Zacks Investment Research downgraded shares of U.S. Physical Therapy, Inc. (NYSE:USPH) from a buy rating to a hold rating in a research report report published on Saturday morning.

According to Zacks, “U.S. Physical Therapy, Inc. operates outpatient physical and occupational therapy clinics which provide post-operative care and treatment for a variety of orthopedic-related disorders and sports-related injuries. “

Several other brokerages have also issued reports on USPH. Barrington Research raised U.S. Physical Therapy from a market perform rating to an outperform rating and set a $68.00 price objective on the stock in a report on Monday, July 3rd. Jefferies Group LLC reaffirmed a hold rating and set a $63.00 price objective on shares of U.S. Physical Therapy in a report on Friday, June 30th. Cantor Fitzgerald initiated coverage on U.S. Physical Therapy in a report on Monday, July 24th. They set an overweight rating and a $72.00 price objective on the stock. Finally, BidaskClub lowered U.S. Physical Therapy from a sell rating to a strong sell rating in a report on Sunday, July 16th. One equities research analyst has rated the stock with a sell rating, three have issued a hold rating and two have assigned a buy rating to the stock. The stock presently has a consensus rating of Hold and an average target price of $68.50.

U.S. Physical Therapy (NYSE USPH) opened at 57.65 on Friday. The stock has a market capitalization of $725.29 million, a PE ratio of 36.49 and a beta of 1.06. The stock’s 50 day moving average price is $61.76 and its 200 day moving average price is $65.33. U.S. Physical Therapy has a 1-year low of $51.96 and a 1-year high of $78.00.

U.S. Physical Therapy (NYSE:USPH) last posted its earnings results on Thursday, August 3rd. The company reported $0.59 EPS for the quarter, missing the consensus estimate of $0.60 by $0.01. The business had revenue of $104.25 million during the quarter, compared to analysts’ expectations of $102.93 million. U.S. Physical Therapy had a net margin of 5.65% and a return on equity of 12.91%. On average, equities research analysts predict that U.S. Physical Therapy will post $2.13 earnings per share for the current fiscal year.

WARNING: This news story was first posted by Watch List News and is the property of of Watch List News. If you are accessing this news story on another domain, it was copied illegally and reposted in violation of US & international trademark & copyright laws. The legal version of this news story can be viewed at https://www.watchlistnews.com/zacks-investment-research-lowers-u-s-physical-therapy-inc-usph-to-hold/1528676.html.

The firm also recently announced a quarterly dividend, which will be paid on Friday, September 8th. Stockholders of record on Monday, August 21st will be paid a dividend of $0.20 per share. The ex-dividend date of this dividend is Thursday, August 17th. This represents a $0.80 annualized dividend and a dividend yield of 1.39%. U.S. Physical Therapy’s dividend payout ratio (DPR) is 46.78%.

In related news, Director Bernard A. Harris, Jr. sold 5,000 shares of the firm’s stock in a transaction dated Thursday, August 10th. The shares were sold at an average price of $62.00, for a total value of $310,000.00. Following the completion of the sale, the director now owns 26,422 shares in the company, valued at $1,638,164. The sale was disclosed in a legal filing with the SEC, which is available through the SEC website. Also, COO Glenn Mcdowell sold 1,664 shares of the firm’s stock in a transaction dated Tuesday, August 22nd. The shares were sold at an average price of $59.91, for a total transaction of $99,690.24. The disclosure for this sale can be found here. Insiders have sold 9,664 shares of company stock valued at $595,810 in the last quarter. Insiders own 3.10% of the company’s stock.

Large investors have recently made changes to their positions in the stock. BlackRock Inc. increased its stake in shares of U.S. Physical Therapy by 166,319.0% in the first quarter. BlackRock Inc. now owns 1,554,353 shares of the company’s stock worth $101,501,000 after buying an additional 1,553,419 shares during the last quarter. Aberdeen Asset Management PLC UK increased its stake in shares of U.S. Physical Therapy by 13.4% in the second quarter. Aberdeen Asset Management PLC UK now owns 705,007 shares of the company’s stock worth $42,582,000 after buying an additional 83,253 shares during the last quarter. Renaissance Technologies LLC increased its stake in shares of U.S. Physical Therapy by 10.4% in the second quarter. Renaissance Technologies LLC now owns 668,074 shares of the company’s stock worth $40,352,000 after buying an additional 63,074 shares during the last quarter. Vanguard Group Inc. increased its stake in shares of U.S. Physical Therapy by 6.5% in the first quarter. Vanguard Group Inc. now owns 641,533 shares of the company’s stock worth $41,892,000 after buying an additional 39,290 shares during the last quarter. Finally, Bridge City Capital LLC purchased a new stake in shares of U.S. Physical Therapy during the second quarter worth approximately $1,760,000. Hedge funds and other institutional investors own 95.50% of the company’s stock.

About U.S. Physical Therapy

U.S. Physical Therapy, Inc, through its subsidiaries, operates outpatient physical therapy clinics that provide pre-and post-operative care, and treatment for orthopedic-related disorders, sports-related injuries, preventative care, rehabilitation of injured workers and neurological-related injuries.

Get a free copy of the Zacks research report on U.S. Physical Therapy (USPH)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Receive News & Ratings for U.S. Physical Therapy Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for U.S. Physical Therapy Inc. and related companies with Analyst Ratings Network's FREE daily email newsletter.